Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/608203
Full metadata record
DC FieldValueLanguage
dc.coverage.spatialChemistry
dc.date.accessioned2024-12-19T11:16:17Z-
dc.date.available2024-12-19T11:16:17Z-
dc.identifier.urihttp://hdl.handle.net/10603/608203-
dc.description.abstractquotAim: Accurate, precise, robust, quick and simple however cost-effective spectrophotometric and chromatographical procedures for quantification of some anti-diabetic drugs in pure and fixed dosage form. newline newlineMaterial and Methods: Various drugs acting as anti-diabetic and their combined pharmaceutical dosage forms i.e. Remogliflozin Etabonate, Vildagliptin Hydrochloride, Metformin Hydrochloride, Teneligliptin Hydrobromide and Pioglitazone Hydrochloride pure drugs were procured from the well-known sources and pharmaceutical dosage forms were purchased from the local medical store. UV- spectroscopic, RP-HPLC and RP-UFLC method to determine assay/content were established and validated as per ICH Q2 (R1) strategies. UFLC methods were also optimized by QbD using Box Behnken Design methodology. Additionally Forced degradation and robustness studies were conducted for HPLC and UFLC methods. newline newline newline newlineResults and Discussion: Determination of Vildagliptin and Remogliflozin was completed by inventing UV spectroscopic and RP-HPLC techniques. Simultaneous determination of Remogliflozin and Metformin was completed by the developed RP-HPLC and RP-UPLC methods, simultaneous estimation of Remogliflozin Etabonate and Teneligliptin Hydrobromide had been carried out by the developing UFLC method; optimization by QbD. Concurrent determination of Metformin hydrochloride, Teneligliptin Hydrobromide and Pioglitazone Hydrochloride had been carried out by the developing UFLC method which was optimization by QbD. Established methods validated as per the ICH Q2 (R1) guidelines. The evaluations of validation were well as per acceptable standards. Forced degradation was executed to certify the probable interference of degradation impurities. Forced degradation studies showed separated peaks of the analytes and degradants. No interference depicted due stress studies for active drugs and degradants. newline newlineConclusion: The anticipated established methodologies were efficaciously validated in accordance to ICH Q2 (R1) and based on outcomes, it was concluded
dc.format.extent-
dc.languageEnglish
dc.relationNo of References 80
dc.rightsuniversity
dc.titleDevelopment and validation of analytical method for selected active pharmaceutical ingredients and dosage form
dc.title.alternative
dc.creator.researcherPanchal, Jigneshkumar
dc.subject.keywordChemistry
dc.subject.keywordChemistry Multidisciplinary
dc.subject.keywordMethod Development
dc.subject.keywordOptimization
dc.subject.keywordPhysical Sciences
dc.subject.keywordQbD and Method Validation
dc.subject.keywordRP HFLC
dc.subject.keywordRP HPLC
dc.subject.keywordSpectroscopy
dc.description.noteReferences p. 144-154
dc.contributor.guideDhalani, Jayesh
dc.publisher.placeRajkot
dc.publisher.universityRK University
dc.publisher.institutionFaculty of Science
dc.date.registered2021
dc.date.completed2024
dc.date.awarded2024
dc.format.dimensions-
dc.format.accompanyingmaterialNone
dc.source.universityUniversity
dc.type.degreePh.D.
Appears in Departments:Faculty of Science



Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).

Altmetric Badge: